International Journal of Hepatology

Research Article

Dilatation Therapy and Demographic Characteristics Significantly Influence the Amount of Propofol for Therapeutic Endoscopic Retrograde Cholangiography

Table 1

Demographic, baseline characteristics, and laboratory parameters of the patient cohort. Patients with different indication for endoscopic retrograde cholangiography (ERC) are compared regarding age, gender, body mass index (BMI), and laboratory parameters at day of first presentation.
 Primary sclerosing cholangitis (n = 153)Bile duct stones (n = 89)Benign stenoses / cholestasis (n = 194)Tumour (n = 169)post-liver transplant cholangiopathy (n = 175)p-value
value/nSDvalue/nSDvalue/nSDvalue/nSDvalue/nSD−
Age (years)42± 1264± 1556 ± 1565± 1151± 12< 0.01
GenderFemale43−54−62−70−71−< 0.01
Male110−35−132−99−104−
Body mass index (kg/m2)24,4 ± 3,826,2± 4,624,8± 5,324,4± 4,825,3± 50.258
C-reactive protein (mg/L)14± 2239 ± 5244± 5649± 5624± 33< 0.01
White blood cells (/µl)7419± 29417674± 33109030± 47958780± 59166493± 2931< 0.01
Platelets (x103/µl)291± 141245± 93274± 131267± 135220± 146< 0.01
Bilirubin (µmol/L)47± 8039± 5377± 117159± 181121± 483< 0.01
Gamma-Glutamyl-transferase (U/L)283± 290441± 496512± 666799± 819549 ± 529< 0.01
Alanine-Aminotransferase (U/L)107± 144128± 20089± 134133± 136124± 151< 0.01
Aspartate-Aminotransferase (U/L)86± 10799± 14276± 97125± 11485± 900.058